← Leaderboards
Caterina Patrizia Minniti
Children'S Research Institute
$1,753,954
Attributed
$1,753,954
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $499.4K · FY2008–20$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
FDA$1,469,867 · 1
NIH$284,087 · 4
By mechanism
R01$1,469,867 · 1
M01$284,087 · 4
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Joseph Scafidi$4,106,734
- Leticia Ryan$809,808
- Lori Luchtman-Jones$1,160,197
- Caterina Minniti$262,967
- Kevin Robert Cleary$15,677,966
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthComputer Retrieval Of Information On Scientific Projects DatabaseGrantChildFundingInstitutionResourcesSourceResearch PersonnelSickle Cell AnemiaTransfusionResponseSafetyOralChronicChildhood InjuryChildhoodBlood VesselsChelating AgentsBlood TransfusionAdultDesignEffectivenessDeferoxamine Methanesulfonate
Grant awards (7)
A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers$489,981
R01 · FY2020 · FD · contact PI
A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers$480,460
R01 · FY2019 · FD · contact PI
A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers$499,426
R01 · FY2017 · FD · contact PI
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL: BABY HUG$118,427
M01 · FY2008 · RR · contact PI
A RANDOMIZED, OPEN-LABEL, MULTI-CENTER PHASE II STUDY TO EVALUATE THE SAFETY$65,716
M01 · FY2008 · RR · contact PI
SILENT CEREBRAL INFARCT MULTI-CENTER TRIAL$56,818
M01 · FY2008 · RR · contact PI
PULMONARY HYPERTENSION AND THE HYPOXIC RESPONSE IN SICKLE CELL DIESEASE:$43,126
M01 · FY2008 · RR · contact PI